Bio Light Wins Canadian Approval for IOPtiMate System

Opthalmic devicemaker Bio Light has snagged Canadian regulatory approval for its IOPtiMate system for the treatment of glaucoma.

The system reduces elevated intraocular pressure by enabling a CO2 laser-assisted procedure known as CO2 Laser-Assisted Sclerotomy Surgery.

Bio Light currently is marketing the system throughout Europe and Asia and is planning to initiate the regulatory approval process for the system in the U.S. — Michael Cipriano